← Back to Patent Explorer
US4002655A Expired / Lapsed US ⏱️ 0.0 years remaining

Glycyrrhetinic acid derivatives

Assignee: Biorex Laboratories Ltd
•
Filing: 1975-02-10
•
Granted: 1977-01-11
•
Expires: 1995-02-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention provides new and pharmaceutically useful amides of the general formula: ##STR1## wherein X is the acyl residue of 18α- or 18β-glycyrrhetinic acid, the 3-hydroxyl group of which can be acylated with a mono-, di- or polybasic inorganic or organic acid, or X is the acyl residue of 3-keto-18α- or -18β-glycyrrhetinic acid; and the metoclopramide salts of those compounds containing at least one free carboxylic acid group.

Inventors

  • 👤 David William Hawkins

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 02:53
CPC Classifications
C; C07; C07J; C07J63/00

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 62 words
A compound selected from the group consisting of compounds of the formula ##STR4## wherein X is the acyl residue of 18α- or 18β-glycyrrhetinic acid, the 3-hydroxyl group of which is optionally acylated with a monobasic fatty acid containing up to 20 carbon atoms or succinic acid and the metoclopramide salt of said compound wherein the 3-hydroxy group is acylated with succinic acid.
Claim 2
Dependent Claim 62 words
A compound selected from the group consisting of compounds of the formula ##STR4## wherein X is the acyl residue of 18α- or 18β-glycyrrhetinic acid, the 3-hydroxyl group of which is optionally acylated with a monobasic fatty acid containing up to 20 carbon atoms or succinic acid and the metoclopramide salt of said compound wherein the 3-hydroxy group is acylated with succinic acid.
Claim 3
Dependent Claim 39 words
A compound according to claim 1, wherein X is the acyl residue of 18α- or 18β-glycyrrhetinic acid, the 3-hydroxyl group of which is optionally acylated with a monobasic fatty acid containing up to 20 carbon atoms or succinic acid.
Claim 4
Dependent Claim 9 words
The compound according to claim 1, which is N-(3β-O-acetyl-18β-glycyrrhetyl)-4-amino-5-chloro-N'-(2-diethylaminoethyl)-2-methoxy-benzamide.
Claim 5
Dependent Claim 9 words
The compound according to claim 1, which is N-(18β-glycyrrhetyl)-4-amino-5-chloro-N'-(2-diethylaminoethyl)-2-methoxy-benzamide.
Claim 6
Dependent Claim 9 words
The compound according to claim 1, which is N-(3β-O-lauroyl-18β-glycyrrhetyl)-4-amino-5-chloro-N'-(2-diethylaminoethyl)-2-methoxy-benzamide.
Claim 7
Dependent Claim 9 words
The compound according to claim 1, which is N-[3β-O-(γ-carboxypropionyl)-18β-glycyrrhetyl]-4-amino-5-chloro-N'-(2-diethylaminoethyl)-2-methoxy-benzamide.

References Cited (Backward Citations)

US3412084A Cited
US3734944A Cited
US3810927A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-01-11 1980-07-12 1981-01-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-01-11 1984-07-12 1985-01-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-01-11 1988-07-12 1989-01-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag